BRIEF published on 04/07/2026 at 08:05, 17 days 9 hours ago Predilife outlines its strategy to maximize its industrial and financial potential Treasury PREDILIFE MammoRisk Industrial Strategy Risk Prediction
BRIEF published on 03/02/2026 at 19:05, 1 month 21 days ago PREDILIFE is making progress in submitting DenSeeRisk to the FDA FDA PREDILIFE MammoRisk Breast Cancer DenSeeRisk
BRIEF published on 01/16/2026 at 18:05, 3 months 7 days ago PREDILIFE's Half-Yearly Review of Liquidity Contract Liquidity Contract Personalized Medicine PREDILIFE Semi-annual Transactions Financial Economy
BRIEF published on 12/17/2025 at 18:35, 4 months 6 days ago Major validation of the MammoRisk strategy against breast cancer PREDILIFE MammoRisk Breast Cancer Personalized Screening WISDOM Study
BRIEF published on 12/10/2025 at 18:05, 4 months 13 days ago PREDILIFE raises €900,000 Artificial Intelligence Fundraising Convertible Bonds Dilution PREDILIFE
BRIEF published on 10/24/2025 at 18:35, 5 months 30 days ago Predilife Publishes its 2025 Half-Yearly Financial Report Artificial Intelligence Euronext Growth Personalized Medicine PREDILIFE 2025 Financial Report
BRIEF published on 10/09/2025 at 18:35, 6 months 14 days ago Predilife: Solid 2025 half-year results despite uncertainties Funding Half-year Results Turnover PREDILIFE Health Forecast
BRIEF published on 07/25/2025 at 18:05, 8 months 29 days ago Balance sheet as of June 30, 2025 of the PREDILIFE Liquidity Contract Liquidity Transactions PREDILIFE Pathologies FASD
BRIEF published on 07/22/2025 at 19:05, 9 months 1 day ago PREDILIFE COMPLETES A PRIVATE PLACEMENT OF €326,000 Private Placement Sales Growth OCEANE Dilution Of Shares Financial Horizon
BRIEF published on 07/03/2025 at 08:05, 9 months 21 days ago Predilife launches a private placement with a growth perspective Private Placement Sales Growth OCEANE PREDILIFE MammoRisk
Published on 04/24/2026 at 15:00, 3 hours 4 minutes ago Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Published on 04/24/2026 at 15:00, 3 hours 4 minutes ago First Canadian Graphite Appoints Scott Kelly As Chief Financial Officer
Published on 04/24/2026 at 14:30, 3 hours 34 minutes ago Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)
Published on 04/24/2026 at 14:00, 4 hours 4 minutes ago Datametrex Expands Patent Monetization Strategy Adding Quantum-Resilient Encryption Technologies
Published on 04/24/2026 at 13:30, 4 hours 34 minutes ago Alset AI Announces Closing of Second Tranche of Loan Transaction of up to $3 Million
Published on 04/24/2026 at 17:45, 19 minutes ago Swiss Life publishes financial condition report – continued strong solvency
Published on 04/24/2026 at 17:45, 19 minutes ago Annual General Meeting of Arbonia AG approves all motions and elects Christoph Ganz as new Chairman of the Board of Directors
Published on 04/24/2026 at 17:21, 43 minutes ago Grand City Properties S.A. announces successful issuance of €600 million perpetual notes and launch of tender offer
Published on 04/24/2026 at 17:18, 45 minutes ago Grand City Properties S.A. announces successful issuance of €600 million perpetual notes and launch of tender offer
Published on 04/24/2026 at 17:08, 55 minutes ago Berliner Effektengesellschaft AG publishes its 2025 separate and consolidated financail statements
Published on 04/24/2026 at 17:45, 19 minutes ago Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026
Published on 04/24/2026 at 16:37, 1 hour 26 minutes ago Availability of the 2025 Universal Registration Document (URD)
Published on 04/23/2026 at 19:27, 22 hours 37 minutes ago Annual Shareholders' Meeting 2026 - Conditions of availability of the preparatory documents
Published on 04/23/2026 at 18:18, 23 hours 45 minutes ago Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
